Pharma.Aero leads the way with the CGT logistics project. White Paper published
The CGT Project team has finalized the White Paper of our Pharma.Aero project that explores the fast-developing sector of Cell and Gene Therapies and the particularities that have an impact on its logistics. The project’s main goal was to broaden the current knowledge of this next-generation market and offer a better understanding of its transportation requirements. Its findings are presented in a White Paper that offers a clearer view and a more detailed perspective on this emerging industry, identifies key logistical challenges and highlights some key points where the supply chain stakeholders could act.
Pharma.Aero enrolled on the project with its global network of over 50 Life Science logistics stakeholders and several external partners and organizations.
▶ Read the CGT White Paper
The project’s first step was to run a market analysis by conducting a thorough desk research on value, type of products, products’ requirements, current logistic capabilities, and constraints.
▶ Read more about the CGT Market Analysis
Following the Market Opportunity Analysis, the project team conducted a survey among the Pharma.Aero members and partners, to capture the level of knowledge, and interest in the ATMP sector and its logistical challenges and opportunities. The survey explored multiple directions, from general knowledge of the sector and logistics, to certification aspects and interest in playing a more important role in the sector’s logistics. The survey provided valuable information on directions worth being further explored and developed. Based on the results of the ATMP internal survey, Pharma.Aero organized a CGT Webinar to further deep dive into the ATMP/CGT sector and its logistical requirements. Experts in the ATMP manufacturing and logistics sector shared first-hand insights and knowledge for a better understanding of the sector and its requirements.
▶ Read more about the CGT Webinar
The White Paper presents a number of key actions that need to be taken to ensure the development of this industry.
Strengthen the skills of the players in the airfreight sector
Facilitate the flow of materials and substances
Reduce time/ Eliminate time loss
Identify products as specific to the CGT industry
Limit regulatory constraints and upgrade CEIV
As an additional positive result of the Pharma.Aero’s CGT Project, many links have been established with industry organizations, manufacturing companies and other, highly specialized, supply chain stakeholders. Pharma.Aero will capitalize on these connections and brainstorm project ideas and other types of collaboration to continue to raise awareness and increase the level of knowledge in the ATMP logistics industry.
Sara Van Lerberghe
Milton De La Paz
Frank Van Gelder
|Biolog Consulting and co-founder of BSMA Europe
Dallas Fort Worth International Airport
Edmonton International Airport
|Project Manager and Expert